Drug
Oxybutynin Chloride
Oxybutynin Chloride: highest development phase Approved, developed by Viatris. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| Oxybutynin Chloride | Approved | |
| Oxybutynin Chloride Extended-release Tablets 5 mg NCT00648843 | Phase 1 | Healthy |
| Oxybutynin Chloride Extended-Release Tablets, 15 mg NCT00649272 | Phase 1 | Healthy |
Latest
No recent events.
Follow Oxybutynin Chloride on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.